Clinical Trials in Hanzhou, Zhejiang
42 recruiting
Showing 1–20 of 37 trials
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled253 locationsNCT05899608
Recruiting
Phase 2
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ascentage Pharma Group Inc.75 enrolled11 locationsNCT05147467
Recruiting
Not Applicable
KD Treatment for Super-refractory Status Epilepticus
Super-refractory Status Epilepticus
Xuanwu Hospital, Beijing84 enrolled15 locationsNCT07496749
Recruiting
Phase 1
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd.130 enrolled11 locationsNCT06375044
Recruiting
Not Applicable
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
Schizophrenia
Sir Run Run Shaw Hospital100 enrolled2 locationsNCT06470516
Recruiting
Micro-movements in Patients With Prolonged Disorders of Consciousness
Consciousness Disorders
First Affiliated Hospital of Zhejiang University179 enrolled1 locationNCT06406413
Recruiting
Phase 1Phase 2
A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd.121 enrolled2 locationsNCT06590246
Recruiting
Phase 1
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University98 enrolled1 locationNCT04778839
Recruiting
Phase 1Phase 2
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled1 locationNCT06556199
Recruiting
Phase 3
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
Rectal Cancer
Sir Run Run Shaw Hospital170 enrolled1 locationNCT06507371
Recruiting
Phase 1Phase 2
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.133 enrolled1 locationNCT05133882
Recruiting
Phase 1
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT05472558
Recruiting
Not Applicable
A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I
Gaucher Disease, Type I
He Huang3 enrolled1 locationNCT06162338
Recruiting
Phase 2
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital20 enrolled2 locationsNCT05557578
Recruiting
Phase 2
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
Low rectal cancer
Sir Run Run Shaw Hospital32 enrolled1 locationNCT05972655
Recruiting
Acute Effects of Meteorological Factors and Air Pollution on Cardiovascular Health
HealthCardiovascular System
The Affiliated Hospital of Hangzhou Normal University350,000 enrolled1 locationNCT06663267
Recruiting
Early Phase 1
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
Aplastic Anemia
Zhejiang University30 enrolled1 locationNCT06633328
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190
Recruiting
Phase 2
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
Refractory or Relapsed Diffuse Large B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University36 enrolled1 locationNCT06554600
Recruiting
Phase 1Phase 2
A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma
PCNSL
Second Affiliated Hospital, School of Medicine, Zhejiang University43 enrolled1 locationNCT06554561